Porto-sinusoidal Vascular Disease (PSVD) is characterized by a portal hypertension (PH) without cirrhosis. This can induce PH complications, like digestive hemorrhage from esophageal or gastric varices, ascites, or even portal thrombosis. Due to the rarity of MVPS, the treatment of complications of portal hypertension is modeled on the methods used in cirrhotic portal hypertension with non-cardio-selective beta blockers, endoscopic ligations or diuretics in first line therapy, as proposed by the Baveno VII recommendations. In complicated or refractory forms of PH in PSVD, the place of TIPS is also discussed, as in the field of cirrhosis. However, the experience of TIPS in PSVD is limited, reported in case reports and small specifically dedicated series. No predictive factors for survival or recurrence and tolerance were well known. A larger study with control group is needed in order to better know the right time and the right indication for the use of TIPS in complicated PH PSVD-related. The study will be retrospective, multicentric involving tertiary university French centers, expert in the management of TIPS. Patients white TIPS-PSVD will be compared with historical patients with TIPS-cirrhose, matched on age, sexe, indication of TIPS. The study will not comprise new intervention, only observational in a real life condition
Study Type
OBSERVATIONAL
Enrollment
360
CHU Amiens Picardie
Amiens, Picardie, France
RECRUITINGoverall survival after TIPS placement
Time frame: at 3 months
overall survival after TIPS placement
Time frame: at 6 months
overall survival after TIPS placement
Time frame: at 1 year
overall survival after TIPS placement
Time frame: at 2 years
overall survival after TIPS placement
Time frame: at 3 years
overall survival after TIPS placement
Time frame: at 4 years
overall survival after TIPS placement
Time frame: at 5 years
free portal hypertension hemorrhage recurrence survival
Time frame: at 3 months
free portal hypertension hemorrhage recurrence survival
Time frame: at 6 months
free portal hypertension hemorrhage recurrence survival
Time frame: at 1 year
free portal hypertension hemorrhage recurrence survival
Time frame: at 2 years
free portal hypertension hemorrhage recurrence survival
Time frame: at 3 years
free portal hypertension hemorrhage recurrence survival
Time frame: at 4 years
free portal hypertension hemorrhage recurrence survival
Time frame: at 5 years
free ascite recurrence survival
Time frame: at 3 months
free ascite recurrence survival
Time frame: at 6 months
free ascite recurrence survival
Time frame: at 1 year
free ascite recurrence survival
Time frame: at 2 years
free ascite recurrence survival
Time frame: at 3 years
free ascite recurrence survival
Time frame: at 4 years
free ascite recurrence survival
Time frame: at 5 years
free TIPS dysfunction survival
Time frame: at 3 months
free TIPS dysfunction survival
Time frame: at 6 months
free TIPS dysfunction survival
Time frame: at 1 year
free TIPS dysfunction survival
Time frame: at 2 years
free TIPS dysfunction survival
Time frame: at 3 years
free TIPS dysfunction survival
Time frame: at 4 years
free TIPS dysfunction survival
Time frame: at 5 years
complication of TIPS placement at D0
Time frame: at 3 months
complication of TIPS placement at D0
Time frame: at 6 months
complication of TIPS placement at D0
Time frame: at 1 year
complication of TIPS placement at D0
Time frame: at 2 years
complication of TIPS placement at D0
Time frame: at 3 years
complication of TIPS placement at D0
Time frame: at 4 years
complication of TIPS placement at D0
Time frame: at 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.